GlassScriptPhysician profile
Cindy Blancq
NPI 1831283472
$5,173.60
in general payments reported to CMS, 2019-2025
19 companies · $584 in 2025
The $584 reported for 2025 was more than what 81% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,351 · 2020: $215 · 2021: $238 · 2022: $797 · 2023: $694 · 2024: $294 · 2025: $584.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,573.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,572.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $2,261.86 | 2019-2021 | |
| Alcon Vision LLC | $659.98 | 2019-2025 | Precision 7, Clareon, Rocklatan |
| Bausch & Lomb Americas INC. | $622.41 | 2022-2025 | Infuse, Xiidra, Alden Scleral Zenlens |
| Johnson & Johnson Vision Care, INC. | $271.94 | 2019-2025 | Acuvue |
| Oyster Point Pharma, INC. | $265.26 | 2022-2023 | Tyrvaya |
| Sun Pharmaceutical Industries INC. | $230.29 | 2019-2024 | Cequa |
| Dompe US, INC. | $155.28 | 2021-2022 | |
| Shire North American Group INC | $129.79 | 2019 | |
| Abbvie INC. | $126.89 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $123.20 | 2019-2023 | |
| Tarsus Pharmaceuticals, INC. | $66.17 | 2024-2025 | Xdemvy |
| Coopervision INC. | $51.46 | 2019-2022 | |
| Eyevance Pharmaceuticals LLC | $50.09 | 2021-2022 | |
| Thea Pharma INC. | $41.68 | 2023-2025 | Iyuzeh |
| Rxsight INC | $31.97 | 2021-2025 | Light Adjustable Lens (Lal), Rxsight Contact Lens, Rxsight Injector Cartridge |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ani Pharmaceuticals, INC. | $28.49 | 2025 | Purified Cortrophin Gel |
| Allergan, INC. | $23.20 | 2019 | |
| Ocular Therapeutix, INC. | $18.26 | 2019 | |
| Beaver-Visitec International, INC. | $15.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cindy Blancq listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.